1. Introduction
===============

In recent years, soft corals have become one of the most prolific sources for the discovery of novel secondary metabolites \[[@B1-marinedrugs-11-03735]\]. Previous chemical investigations on soft corals of the genus *Lemnalia* have led to the isolation and identification of variety of ylangene-derived sesquiterpenoids \[[@B2-marinedrugs-11-03735],[@B3-marinedrugs-11-03735],[@B4-marinedrugs-11-03735],[@B5-marinedrugs-11-03735]\]. Some of these have been found to possess various biological activities, such as cytotoxic \[[@B4-marinedrugs-11-03735]\] and anti-inflammatory properties \[[@B6-marinedrugs-11-03735]\]. Using our experience searching for new bioactive metabolites from soft corals of *Lemnalia* \[[@B7-marinedrugs-11-03735]\] and *Paralemnalia* \[[@B8-marinedrugs-11-03735],[@B9-marinedrugs-11-03735],[@B10-marinedrugs-11-03735],[@B11-marinedrugs-11-03735]\], we carried out the first chemical investigation of the soft coral *Lemnalia philippinensis* with the aim of discovering interesting new metabolites. Our chemical examination of this soft coral led to the isolation of two new oxygenated ylangene-type sesquiterpenoids, philippinlins A and B (**1** and **2**), and one known compound lemnalol (**3**) \[[@B2-marinedrugs-11-03735]\]. The structures of **1**--**3** were established by detailed spectroscopic analysis, including extensive examination of 2D NMR (COSY, HSQC, HMBC and NOESY) correlations. The cytotoxicity of metabolites **1**--**3** towards human liver carcinoma (HepG2), human breast carcinoma (MDA-MB231) and human lung adenocarcinoma epithelial cells (A549) was evaluated, and **1** was found to be cytotoxic against the above cancer cells.

2. Results and Discussion
=========================

The EtOAc extract of the frozen specimen was fractionated by silica gel column chromatography and the eluted fractions were further separated utilizing normal phase HPLC to yield metabolites **1**--**3** ([Figure 1](#marinedrugs-11-03735-f001){ref-type="fig"}). The new compounds were given the trivial names philippinlins A and B (**1** and **2**). By comparison of NMR and MS data, compound **3** was found to be identical with known lemnalol \[[@B2-marinedrugs-11-03735]\]. The specific optical rotation of **3** (\[α\]^25^~D~ −8.0) was close to that reported for lemnalol (\[α\]^25^~D~ −9.3) \[[@B2-marinedrugs-11-03735]\],which ensures that we are dealing with the same enantiomer. Compounds **1** and **2** were isolated with **3** from the same organism and should be formed by a shared biosynthetic pathway. Thus, both new compounds are suggested to possess the absolute configurations as shown in formulae **1** and **2**.

![The soft coral *Lemnalia philippinensis* and the structures of philippinlins A (**1**), B (**2**), and lemnalol (**3**).](marinedrugs-11-03735-g001){#marinedrugs-11-03735-f001}

Philippinlin A (**1**) was obtained as a colorless oil. The HRESIMS of **1** exhibited a pseudomolecular ion peak at *m*/*z* 259.1672 \[M + Na\]^+^, and established a molecular formula of C~15~H~24~O~2~, implying four degrees of unsaturation. IR absorptions were observed at 3437 and 1714 cm^−1^, suggesting the presence of hydroxy and carbonyl groups in **1**. In the ^13^C NMR and DEPT spectroscopic data ([Table 1](#marinedrugs-11-03735-t001){ref-type="table"}), signals of three methyls, four sp^3^ methylenes (including one oxymethylene), six sp^3^ methines, one sp^3^ quaternary carbon and one ketone were observed. From the ^1^H NMR spectrum of **1**, the signals of one oxygenated methylene (δ 3.91, dd, *J* = 10.5 and 8.5 Hz; 3.55, dd, *J* = 10.5 and 5.5 Hz) and three methyls (δ 0.90, s; 0.87, d, *J* = 7.0 Hz; 0.85, d, *J* = 7.0 Hz) were observed. The planar structure and all of the ^1^H and ^13^C chemical shifts of **1** were elucidated by 2D NMR spectroscopic analysis, in particular COSY and HMBC experiments ([Figure 2](#marinedrugs-11-03735-f002){ref-type="fig"}). To establish the proton sequences in **1**, the ^1^H-^1^H COSY spectrum analysis established two proton sequences ([Figure 2](#marinedrugs-11-03735-f002){ref-type="fig"}). The molecular framework of **1** was further established by an HMBC experiment, which showed the following key correlations ([Figure 2](#marinedrugs-11-03735-f002){ref-type="fig"}): H~2~-5 to C-4, C-6 and C-7, H-6 to C-7, H-7 to C-1, H~3~-11 to C-1, C-2, C-6 and C-10, H~2~-12 to C-2, C-3 and C-4, both methyls H~3~-14 and H~3~-15 to C-8 and C-13. From above results and the chemical shifts of CH~2~-12 and C-4 ([Table 1](#marinedrugs-11-03735-t001){ref-type="table"}), **1** was found to possess a hydroxy group at C-12, and a ketone group at C-4. Furthermore, analysis of the ^1^H and ^13^C NMR data showed that the partial structures from C-1, C-2 and C-6 to C-15 in **1** should be identical to those of **3**. The relative configurations of all stereocenters, except C-3 and C-4 of **1**, were confirmed to be the same as those of **3** by comparison of the proton shifts and NOE correlations ([Figure 3](#marinedrugs-11-03735-f003){ref-type="fig"}). One hydroxymethyl group at C-3 was assigned the *α*-configuration primarily due to the NOE correlation between H-3 and H~3~-11. Thus, the structure of sesquiterpenoid **1** was established.
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###### 

^13^C and ^1^H NMR spectral data for compounds **1** and **2.**

  -----------------------------------------------------------------------------
  \     1              2                                       
  C/H                                                          
  ----- -------------- ------------------------ -------------- ----------------
  1     41.6 (C)                                48.9 (C)       

  2     37.3 (CH)      2.07 dd (7.0, 2.0)       40.9 (CH)      2.24 d (6.0)

  3     51.5 (CH)      2.74 ddd                 150.3 (C)      

                       (8.5, 5.5, 2.0)                         

  4     216.7 (C)                               119.7 (CH)     5.66 brs

  5     43.5 (CH~2~)   α: 2.69 dd (19.0, 1.5)   70.2 (CH)      4.36 brs

                       β: 2.52 dd (19.0, 3.5)                  

  6     46.2 (CH)      1.70 m                   54.8 (CH)      1.82 m

  7     42.8 (CH)      1.74 m                   42.3 (CH)      1.89 m

  8     44.2 (CH)      1.65 m                   44.9 (CH)      1.60 m

  9     21.6 (CH~2~)   1.70 m; 1.59 m           21.9 (CH~2~)   1.67 m; 1.59 m

  10    36.3 (CH~2~)   1.79 m; 1.71 m           36.8 (CH~2~)   1.73 m

  11    18.2 (CH~3~)   0.90 s                   19.1 (CH~3~)   0.82 s

  12    63.4 (CH~2~)   3.91 dd (10.5, 8.5)      65.4 (CH~2~)   4.06 s

                       3.55 dd (10.5, 5.5)                     

  13    32.4 (CH)      1.50 m                   32.5 (CH)      1.58 m

  14    19.8 (CH~3~)   0.85 d (7.0)             19.4 (CH~3~)   0.87 d (6.4)

  15    19.5 (CH~3~)   0.87 d (7.0)             20.0 (CH~3~)   0.86 d (6.4)
  -----------------------------------------------------------------------------

Spectra recorded at *^a^* 125 MHz in CDCl~3~; *^b^* 500 MHz in CDCl~3~; *^c^* 100 MHz in CDCl~3~; *^d^* 400 MHz in CDCl~3~.

![Selected COSY (▬) and HMBC (→) correlations of **1** and **2**.](marinedrugs-11-03735-g002){#marinedrugs-11-03735-f002}

![Key NOESY correlations for **1** and **2**.](marinedrugs-11-03735-g003){#marinedrugs-11-03735-f003}

Philippinlin B (**2**) was obtained as a white powder and showed a \[M + Na\]^+^ ion peak in the HRESIMS spectrum corresponding to the molecular formula C~15~H~24~O~2~, the same as that of **1**. IR absorption was observed at 3358 cm^−1^, again suggesting the presence of the hydroxy group in **2**. Also, unlike **1**, the absence of carbonyl absorption was shown in the IR spectrum. The planar structure and all of the ^1^H and ^13^C chemical shifts of **2** were elucidated by 2D NMR spectroscopic analysis, in particular COSY and HMBC experiments ([Figure 2](#marinedrugs-11-03735-f002){ref-type="fig"}). Thus, **2** was found to possess one double bond at C-3/C-4, two hydroxy groups at C-5 and C-12. The relative configurations of the six chiral centers at C-1, C-2, C-5, C-6, C-7 and C-8 in **2** were elucidated by detailed NOE analysis, as shown in [Figure 2](#marinedrugs-11-03735-f002){ref-type="fig"}. In these experiments, it was found that H-5 showed NOE interactions with H-6 and H~3~-11. Thus, assuming the *β*-orientation of H-5, both H-6 and H~3~-11 should be positioned on the *β* face. On the basis of the above findings and detailed examination of other NOE correlations ([Figure 3](#marinedrugs-11-03735-f003){ref-type="fig"}), the relative structure of compound **2** was determined.

The cytotoxicity of metabolites **1**--**3** against the growth of HepG2, MDA-MB231 and A549 carcinoma cells was studied. Compound **1** showed cytotoxicity towards HepG2, MDA-MB231, and A549 cancer cell lines with IC~50~ values of 16.0, 16.3, and 15.8 μg/mL, respectively. While lemnalol has been shown to possess remarkable anti-inflammatory activities \[[@B6-marinedrugs-11-03735],[@B12-marinedrugs-11-03735],[@B13-marinedrugs-11-03735]\], compounds **2** and **3** did not exhibit cytotoxicity towards the above cancer cell lines.

3. Experimental Section
=======================

3.1. General Experimental Procedures
------------------------------------

Optical rotation values were measured with a Jasco-P1010 digital polarimeter. Infrared spectra were obtained on a Varian Diglab FTS 1000 FT-IR spectrophotometer. NMR spectra were recorded on a Varian Mercury Plus 400 FT-NMR at 400 MHz for ^1^H and 100 MHz for ^13^C in CDCl~3~or C~5~D~5~N at 25 °C. ESIMS and HRESIMS data were recorded on a Bruker APEX II mass spectrometer. Column chromatography was performed on silica gel (230--400 mesh, Merck, Darmstadt, Germany). TLC was carried out on precoated Kieselgel 60 F~254~ (0.25 mm, Merck, Darmstadt, Germany) and spots were visualized by spraying with 10% H~2~SO~4~ solution followed by heating. Normal phase HPLC (NP-HPLC) was performed using a system comprised of a Hitachi L-7110 pump, a Hitachi L-7455 photodiode array detector and a Rheodyne 7725 injection port. A normal phase column (Supelco Ascentis^®^ Si Cat \#:581515-U, 25 cm × 21.2 mm, 5 μm) was used for NP-HPLC. Reverse phase HPLC (RP-HPLC) was performed using a system comprised of a Hitachi L-7100 pump, a Hitachi L-2455 photodiode array detector and a Rheodyne 7725 injection port. A reverse phase column (Varian Polaris C18-A, 250 mm × 10 mm, 5 μm) was used for RP-HPLC.

3.2. Animal Material
--------------------

*L. philippinensis*, taxonomically identified by Prof. Chang-Feng Dai of National Taiwan University, was collected by hand using scuba off the coast of Lanyu, Taiwan, in August 2008, at a depth of 10--15 m, and stored in a freezer until extraction. A voucher sample was deposited at the Department of Marine Biotechnology and Resources, National Sun Yat-sen University*.*

3.3. Extraction and Isolation
-----------------------------

Sliced tissues of the soft coral *L. philippinensis* (0.8 kg, wet wt) were exhaustively extracted with EtOAc. The combined EtOAc extract was concentrated under reduced pressure. The EtOAc extract was evaporated to yield a residue (10.7 g), which was subjected to open column chromatography on silica gel stepwisely eluting with *n*-hexane-EtOAc mixture and EtOAc-MeOH mixture, to give 25 fractions. Fraction 7, eluted with *n*-hexane--EtOAc (20:1), was further separated by Sephadex LH-20 column chromatography with acetone as eluent to yield 5 subfractions (7A--E). Subfraction 7D was separated by silica gel open column chromatography with gradient elution (*n*-hexane--CH~2~Cl~2~, 4:1) to afford **3** (156 mg) and subfraction 7E was also separated by normal phase HPLC using *n*-hexane--CH~2~Cl~2~ (4:1) to afford **1** (3.9 mg). The combined fractions 18 and 19, eluted with *n*-hexane--EtOAc (1:1--1:2), were separated by silica gel open column chromatography with gradient elution (*n*-hexane--EtOAc, 7:2) to yield 8 subfractions (18A--H). Subfraction 18G was separated by normal phase HPLC using *n*-hexane--EtOAc (2:1) to afford **2** (1.1 mg).

Philippinlin A (**1**): colorless oil; \[α\]^25^~D~ = −97 (*c* 0.3, CHCl~3~); IR (neat) ν~max~ 3437, 2941, 1714, 1459 and 1376 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-11-03735-t001){ref-type="table"}; ESIMS *m*/*z* 259 \[M + Na\]^+^; HRESIMS *m*/*z* 259.1672 (calcd. for C~15~H~24~O~2~Na, 259.1674).

Philippinlin B (**2**): white powder; mp 92--93 °C; \[α\]^25^~D~ = +39 (c 0.1, CHCl~3~); IR (neat) ν~max~ 3358, 2932, 2862 and 1464 cm^−1^; ^1^H and ^13^C NMR data, see [Table 1](#marinedrugs-11-03735-t001){ref-type="table"}; ESIMS *m*/*z* 259 \[M + Na\]^+^; HRESIMS *m*/*z* 259.1672 (calcd. for C~15~H~24~O~2~Na, 259.1674).

3.4. Cytotoxicity Testing
-------------------------

Cell lines were purchased from the American Type Culture Collection (ATCC). Cytotoxicity assays of compounds **1**--**3** were performed using the MTT \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] colorimetric method \[[@B14-marinedrugs-11-03735],[@B15-marinedrugs-11-03735]\]. Doxorubicin, employed as positive control, exhibited cytotoxic activity toward HepG2, MDA-MB231 and A549 cancer cell lines with IC~50~'s 0.4, 1.4, and 1.6 μg/mL, respectively.

4. Conclusions
==============

Two new oxygenated ylangene-derived compounds, philippinlins A (**1**) and B (**2**) and a known compound lemnalol (**3**), were discovered from the soft coral *L*. *philippinensis*. Compound **1** was found to exhibit cytotoxicity towards HepG2, MDA-MB231 and A549 cancer cell lines.
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